KVP International, Inc.

KVP International, Inc. specializes in gloves and wound care products. Their primary offerings include nitrile and hevea-latex examination and treatment gloves, both non-powdered and non-antimicrobial, as well as adhesive bandages. These devices are designed for medical, clinical, and veterinary applications, providing barrier protection and wound care solutions. The company also produces branded lines like VetOne and mVet, which cater specifically to animal healthcare settings.

KVP International, Inc. is based in the United States. Since its devices fall under U.S. regulatory jurisdiction, the company must comply with domestic requirements, including listing its products in the FDA’s Unique Device Identification (UDI) system. This system ensures traceability and transparency for Class I devices, which are subject to minimal regulatory oversight due to their low-risk classification.

KVP International, Inc.’s devices are listed in the FDA’s Unique Device Identification (UDI) system. The FDA mandates UDI for Class I devices to improve tracking, reduce medical errors, and ensure compliance with U.S. regulatory standards. Since these devices are classified as Class I—considered low-risk—they require this level of identification to maintain transparency and accountability in the healthcare supply chain.

KVP International, Inc.’s devices are classified as Class I medical devices. This classification is based on their intended use and risk level, where these products are deemed low-risk and generally pose minimal harm to users. As a result, they are subject to the least stringent regulatory controls, primarily requiring compliance with general controls (e.g., good manufacturing practices) and mandatory UDI listing to ensure traceability and market oversight.